
Sign up to save your podcasts
Or

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
5
11 ratings
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

2 Listeners

1 Listeners

0 Listeners
0 Listeners

1 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners